Status:
WITHDRAWN
Study to Evaluate the Effectiveness of SGB in Preventing Post-op Atrial Fibrillation
Lead Sponsor:
Christopher Connors, MD
Conditions:
Atrial Fibrillation
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
Atrial fibrillation requires both an initiation trigger and favorable environment for maintenance and the sympathetic and parasympathetic nervous systems play important roles in this regard. Unfortuna...
Detailed Description
The investigator's hypothesis is that perioperative SGB in cardiac surgery will decrease POAF. To address this, the investigator will: 1. Recruit 707 patients to undergo perioperative SGB prior to ca...
Eligibility Criteria
Inclusion
- scheduled for non-emergent CABG, AVR, or CABG/AVR
- aged at least 18 years
- English speaking
Exclusion
- aged less than 18 years
- pregnant women
- prisoners
- patients having emergency surgery
- patients with clinical contraindications to SGB (including allergy to local anesthetic, carotid vascular disease as defined by ipsilateral prior carotid endarterectomy or carotid stent, superficial infection at the proposed puncture site, contralateral phrenic or laryngeal nerve palsies, and severe chronic obstructive pulmonary disease as defined by the need for home oxygen)
- patients who are unable to provide informed consent for themselves
- patients with a history of atrial fibrillation
Key Trial Info
Start Date :
December 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2021
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT03269383
Start Date
December 1 2019
End Date
December 1 2021
Last Update
April 24 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Maine Medical Center
Portland, Maine, United States, 04102